Editas Medicine (EDIT) Free Cash Flow (2015 - 2025)
Editas Medicine (EDIT) reported Free Cash Flow of -$30.7 million for Q3 2025, up 44.64% year-over-year from -$21.2 million in Q3 2024, and up 38.8% on a QoQ basis from -$50.2 million in Q2 2025.
Editas Medicine (EDIT) has 11 years of Free Cash Flow data on file, last reported at -$30.7 million in Q3 2025.
- Quarterly Free Cash Flow rose 44.64% year-over-year to -$30.7 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$128.9 million (up 38.74% YoY) and the FY2024 annual result came in at -$210.3 million, down 58.13% from the prior year.
- Free Cash Flow rose to -$30.7 million in Q3 2025 per EDIT's latest filing, from -$50.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$19.7 million in Q4 2023 and bottomed at -$60.6 million in Q2 2024.
- The 5-year median for Free Cash Flow is -$42.5 million (2024), against an average of -$43.1 million.
- The widest annual swing landed in 2023, when Free Cash Flow surged 54.14%; it then sank 116.24% in 2024.
- Tracing EDIT's Free Cash Flow over 5 years: stood at -$34.7 million in 2021, then dropped by 23.5% to -$42.9 million in 2022, then surged by 54.14% to -$19.7 million in 2023, then slumped by 116.24% to -$42.5 million in 2024, then increased by 27.77% to -$30.7 million in 2025.
- Per Business Quant, the three latest EDIT Free Cash Flow figures stand at -$30.7 million (Q3 2025), -$50.2 million (Q2 2025), and -$47.9 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.73 Mn |
| Sep 30, 2025 | -30.73 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Mar 31, 2025 | -47.91 Mn |
| Mar 31, 2025 | -47.91 Mn |
| Dec 31, 2024 | -42.54 Mn |
| Dec 31, 2024 | -42.54 Mn |
| Sep 30, 2024 | -55.51 Mn |
| Sep 30, 2024 | -55.51 Mn |
| Jun 30, 2024 | -60.56 Mn |
| Jun 30, 2024 | -60.56 Mn |
| Mar 31, 2024 | -51.74 Mn |
| Mar 31, 2024 | -51.74 Mn |
| Dec 31, 2023 | -19.67 Mn |
| Dec 31, 2023 | -19.67 Mn |
| Sep 30, 2023 | -38.66 Mn |
| Sep 30, 2023 | -38.66 Mn |
| Jun 30, 2023 | -37.08 Mn |
| Jun 30, 2023 | -37.08 Mn |
| Mar 31, 2023 | -37.61 Mn |
| Mar 31, 2023 | -37.61 Mn |
| Dec 31, 2022 | -42.90 Mn |
| Dec 31, 2022 | -42.90 Mn |
| Sep 30, 2022 | -51.37 Mn |
| Sep 30, 2022 | -51.37 Mn |
| Jun 30, 2022 | -35.72 Mn |
| Jun 30, 2022 | -35.72 Mn |
| Mar 31, 2022 | -51.48 Mn |
| Mar 31, 2022 | -51.48 Mn |
| Dec 31, 2021 | -34.73 Mn |
| Dec 31, 2021 | -34.73 Mn |
| Sep 30, 2021 | -40.30 Mn |
| Sep 30, 2021 | -40.30 Mn |
| Jun 30, 2021 | -39.95 Mn |
| Jun 30, 2021 | -39.95 Mn |
| Mar 31, 2021 | -49.56 Mn |
| Mar 31, 2021 | -49.56 Mn |
| Dec 31, 2020 | -39.85 Mn |
| Dec 31, 2020 | -39.85 Mn |
| Sep 30, 2020 | -51.72 Mn |
| Sep 30, 2020 | -51.72 Mn |
| Jun 30, 2020 | -32.70 Mn |
| Jun 30, 2020 | -32.70 Mn |
| Mar 31, 2020 | -56.24 Mn |
| Mar 31, 2020 | -56.24 Mn |
| Dec 31, 2019 | 44.77 Mn |
| Dec 31, 2019 | 44.77 Mn |
| Sep 30, 2019 | -31.26 Mn |
| Sep 30, 2019 | -31.26 Mn |
| Jun 30, 2019 | -25.55 Mn |
| Jun 30, 2019 | -25.55 Mn |
| Mar 31, 2019 | -29.36 Mn |
| Mar 31, 2019 | -29.36 Mn |
| Dec 31, 2018 | 4.01 Mn |
| Dec 31, 2018 | 4.01 Mn |
| Sep 30, 2018 | -10.81 Mn |
| Sep 30, 2018 | -10.81 Mn |
| Jun 30, 2018 | -16.98 Mn |
| Jun 30, 2018 | -16.98 Mn |
| Mar 31, 2018 | -22.59 Mn |
| Mar 31, 2018 | -22.59 Mn |
| Sep 30, 2017 | 13.88 Mn |
| Sep 30, 2017 | 13.88 Mn |
| Jun 30, 2017 | 42.61 Mn |
| Jun 30, 2017 | 42.61 Mn |
| Mar 31, 2017 | 69.14 Mn |
| Mar 31, 2017 | 69.14 Mn |
| Dec 31, 2016 | -16.93 Mn |
| Dec 31, 2016 | -16.93 Mn |
| Sep 30, 2016 | -15.18 Mn |
| Sep 30, 2016 | -15.18 Mn |
| Jun 30, 2016 | -11.48 Mn |
| Jun 30, 2016 | -11.48 Mn |
| Mar 31, 2016 | -10.16 Mn |
| Mar 31, 2016 | -10.16 Mn |
| Dec 31, 2015 | -8.41 Mn |
| Dec 31, 2015 | -8.41 Mn |
| Sep 30, 2015 | -12.13 Mn |
| Sep 30, 2015 | -12.13 Mn |
| Jun 30, 2015 | 19.72 Mn |
| Jun 30, 2015 | 19.72 Mn |
| Mar 31, 2015 | -6.06 Mn |
| Mar 31, 2015 | -6.06 Mn |